PASW (Ping An Biomedical Co) Current Deferred Revenue: $0.01 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PASW Ping An Biomedical Co Ltd PASW
17 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Ping An Biomedical Co Current Deferred Revenue?

Ping An Biomedical Co PASW -6.49% 17 Current Deferred Revenue is $0.01 Mil as of Sep. 2025. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Ping An Biomedical Co's current deferred revenue for the quarter that ended in Sep. 2025 was $0.01 Mil.

Ping An Biomedical Co Current Deferred Revenue Related Terms

Ping An Biomedical Co Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Ping An Biomedical Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ping An Biomedical Co Current Deferred Revenue Chart

Ping An Biomedical Co Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
Current Deferred Revenue
0.26 0.04 0.07 0.24 0.01

Ping An Biomedical Co Semi-Annual Data
Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only 0.07 0.01 0.24 0.11 0.01
PASW
17GF Score
Ping An Biomedical Co Ltd PASW
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0.01 Mil mean?
Ping An Biomedical Co (PASW) has a Current Deferred Revenue of $0.01 Mil as of Sep. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Ping An Biomedical Co and its competitors.
Is Ping An Biomedical Co's Current Deferred Revenue too high?
Ping An Biomedical Co's current Current Deferred Revenue is $0.01 Mil. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's Current Deferred Revenue compare to DXYN and CULP?
Ping An Biomedical Co's Current Deferred Revenue of $0.01 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Manufacturing - Apparel & Accessories company?
A good Current Deferred Revenue depends on the Manufacturing - Apparel & Accessories industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Ping An Biomedical Co and its competitors. Ping An Biomedical Co's current Current Deferred Revenue is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current Current Deferred Revenue of $0.01 Mil. The current Current Deferred Revenue is $0.01 Mil. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current Current Deferred Revenue is $0.01 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ping An Biomedical Co Business Description

Address Tai Nan West Street, 1002-1008, 22nd Floor, China United Plaza, Cheung Sha Wan, Kowloon, Hong Kong, HKG
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score

Get the complete analysis for PASW

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price